dacarbazine and Hepatitis

dacarbazine has been researched along with Hepatitis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kolarović, J; Lalić-Popović, M; Lalošević, D; Mikov, M; Milijašević, B; Stefanović, D; Tomić, Z1
Bronder, E; Garbe, E; Herbst, H; Kauffmann, W; Klimpel, A; Orzechowski, HD; Sarganas, G; Thomae, M1

Reviews

1 review(s) available for dacarbazine and Hepatitis

ArticleYear
Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system.
    Neuro-oncology, 2012, Volume: 14, Issue:5

    Topics: Adverse Drug Reaction Reporting Systems; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Cholestasis; Dacarbazine; Glioblastoma; Hepatitis; Humans; Male; Middle Aged; Prognosis; Temozolomide; United States; United States Food and Drug Administration

2012

Other Studies

1 other study(ies) available for dacarbazine and Hepatitis

ArticleYear
Acute toxic effects of single dose dacarbazine: hematological and histological changes in an animal model.
    Biotechnic & histochemistry : official publication of the Biological Stain Commission, 2014, Volume: 89, Issue:8

    Topics: Animals; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Chemical and Drug Induced Liver Injury; Cricetinae; Dacarbazine; Dose-Response Relationship, Drug; Fibrosarcoma; Hematologic Diseases; Hepatitis; Humans; Male; Pneumonia; Treatment Outcome

2014